Hydroxycarbamide

From WikiMD's WELLNESSPEDIA

(Redirected from Hydrea)

Hydroxycarbamide (Hydroxyurea)[edit]

File:HYDREA (ハイドレア).jpg
Hydroxyurea capsules, commonly used in the treatment of certain blood disorders and cancers.

Hydroxycarbamide, also known as hydroxyurea, is a medication widely used in the treatment of various diseases, including sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia, and cervical cancer.


Medical Uses[edit]

Hydroxycarbamide is employed in the management of:

Mechanism of Action[edit]

File:Hydroxyurea.svg
Diagram illustrating the mechanism of action of hydroxyurea.

Hydroxycarbamide works by inhibiting ribonucleotide reductase, an enzyme crucial for DNA synthesis. This action helps in reducing the proliferation of rapidly dividing cells.

History[edit]

Hydroxycarbamide was first approved for medical use in the United States in 1967. It represented a significant advancement in the treatment of certain blood disorders and cancers.

Availability and Essential Medicine Status[edit]

File:World Health Organization Logo.svg
The WHO has listed hydroxycarbamide on its List of Essential Medicines.

It is included in the World Health Organization's List of Essential Medicines, highlighting its importance in a health system. Hydroxycarbamide is available as a generic medication, making it accessible and affordable.

External Links[edit]


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.